Videos

Videos

Exploring Non-Chemotherapy Options for the Frontline Treatment of Patients With Mantle Cell Lymphoma

07/28/2024

At the 2024 Great Debates & Updates meeting, Tycel Phillips, MD, participated in a debate about the role of non-chemotherapy regimens for the treatment of patients with newly diagnosed mantle cell lymphoma.

At the 2024 Great Debates &...

07/28/2024

Lymphoma, Leukemia & Myeloma Network

Videos

Daratumumab Plus Bortezomib, Lenalidomide and Dexamethasone for Transplant-Eligible Patients With Newly Diagnosed MM

07/27/2024

Paula Rodríguez-Otero, MD, highlights results supporting the use of daratumumab plus bortezomib, lenalidomide and dexamethasone as a standard of care treatment for transplant-eligible patients with newly diagnosed multiple myeloma.

Paula Rodríguez-Otero, MD,...

07/27/2024

Oncology

Clinical Videos

Rare Case of Myocardial “Milking” in a Diagonal Branch Artery

07/26/2024

Richard Casazza , MAS, RT(R)(CI);

David J. Epstein , MD;

Nicole DeLeon , MD;

Enrico Montagna , RT(R)(CI);

Isa Sarro ;

Arsalan Hashmi , MD;

Video Supplement to "Rare Case of Myocardial “Milking” in a Diagonal Branch Artery" (Clinical Image).

Video Supplement to "Rare Case...

07/26/2024

Journal of Invasive Cardiology

Videos

Zilurgisertib Alone or Combined With Ruxolitinib Well-Tolerated Among Patients With Myelofibrosis

07/25/2024

Prithviraj Bose, MD, shares results from an ongoing study that demonstrate that zilurgisertib as monotherapy or in combination with ruxolitinib had a favorable tolerance profile among patients with myelofibrosis.

Prithviraj Bose, MD, shares...

07/25/2024

Oncology

Sponsored Video

RECELL® Spray-On™ Skin Cells: Innovation for Closure of Full-thickness Wounds

07/24/2024

Join Dr. Lisa Gould, Plastic Surgeon, as she shares her clinical experience using RECELL Spray-On Skin Cells. The RECELL System technology platform treats patients with thermal burn wound and full-thickness skin defects and is used for...

Join Dr. Lisa Gould, Plastic...

07/24/2024

Wound Care

Conference Coverage

CAR T-Cell Therapy as New Standard of Care for Patients With Early Relapsed Large B-Cell Lymphoma

07/23/2024

Jason Westin, MD, shares expert insight regarding CAR T-cell therapy as standard of care treatment for patients with early relapsed large B-cell lymphoma at the 2024 Pan Pacific Lymphoma Conference.

Jason Westin, MD, shares expert...

07/23/2024

Oncology

Videos

Characteristics of Clinical Trials in Community Oncology Practices Across the US

07/23/2024

Ivy Altomare , MD;

Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.

Ivy Altomare, MD, provides an...

07/23/2024

Journal of Clinical Pathways

Rapid Refresh

Understanding the Role of BCMA in Cancer Pathogenesis

07/23/2024

This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.

This animation explains the role...

07/23/2024

APP Institute Oncology

Rapid Refresh

Understanding the Role of BCL2 in Cancer Pathogenesis

07/23/2024

This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.

This animation discusses the...

07/23/2024

APP Institute Oncology

Rapid Refresh

Understanding the Role of ALK in Cancer Pathogenesis

07/23/2024

This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.

This animation explains the role...

07/23/2024

APP Institute Oncology